Great Point Partners as of March 31, 2024
Portfolio Holdings for Great Point Partners
Great Point Partners holds 35 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurogene (NGNE) | 8.0 | $51M | 1.0M | 50.90 | |
| Alpine Immune Sciences | 7.0 | $45M | 1.1M | 39.64 | |
| Urogen Pharma (URGN) | 6.1 | $39M | 2.6M | 15.00 | |
| Abivax Sa Sponsored Ads (ABVX) | 5.5 | $36M | 2.5M | 14.30 | |
| Evolus (EOLS) | 5.3 | $34M | 2.5M | 14.00 | |
| Pliant Therapeutics (PLRX) | 4.3 | $28M | 1.9M | 14.90 | |
| Apogee Therapeutics (APGE) | 4.1 | $27M | 400k | 66.45 | |
| Aerovate Therapeutics (AVTE) | 4.1 | $26M | 888k | 29.57 | |
| Miragen Therapeutics (VRDN) | 3.6 | $23M | 1.3M | 17.51 | |
| Anaptysbio Inc Common (ANAB) | 3.4 | $22M | 977k | 22.52 | |
| Esperion Therapeutics (ESPR) | 3.3 | $21M | 8.0M | 2.68 | |
| Insmed Com Par $.01 (INSM) | 3.3 | $21M | 776k | 27.13 | |
| Arcellx Common Stock (ACLX) | 3.3 | $21M | 300k | 69.55 | |
| Xenon Pharmaceuticals (XENE) | 3.1 | $20M | 456k | 43.05 | |
| Mind Medicine Mindmed Com New (MNMD) | 2.9 | $19M | 2.0M | 9.40 | |
| Dianthus Therapeutics (DNTH) | 2.9 | $19M | 625k | 30.00 | |
| Outlook Therapeutics (OTLK) | 2.8 | $18M | 1.5M | 11.94 | |
| Amicus Therapeutics (FOLD) | 2.7 | $18M | 1.5M | 11.78 | |
| Ocular Therapeutix (OCUL) | 2.5 | $16M | 1.7M | 9.10 | |
| Dynavax Technologies Corp Com New (DVAX) | 2.4 | $16M | 1.3M | 12.41 | |
| Cytokinetics Com New (CYTK) | 2.2 | $14M | 202k | 70.11 | |
| Optinose | 2.0 | $13M | 8.8M | 1.46 | |
| Jasper Therapeutics Com New (JSPR) | 1.9 | $12M | 408k | 29.36 | |
| Intra Cellular Therapies (ITCI) | 1.6 | $10M | 150k | 69.20 | |
| Merus N V (MRUS) | 1.6 | $10M | 223k | 45.03 | |
| Vistagen Therapeutics Ord (VTGN) | 1.5 | $9.8M | 1.9M | 5.28 | |
| Terns Pharmaceuticals (TERN) | 1.3 | $8.6M | 1.3M | 6.56 | |
| Immunocore Hldgs Ads (IMCR) | 1.2 | $7.5M | 115k | 65.00 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.2 | $7.4M | 1.2M | 6.38 | |
| Puma Biotechnology (PBYI) | 1.1 | $7.1M | 1.3M | 5.30 | |
| Zura Bio Class A Ord Shs (ZURA) | 1.1 | $7.1M | 2.8M | 2.57 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.8 | $5.2M | 500k | 10.40 | |
| Spyre Therapeutics Com New (SYRE) | 0.7 | $4.7M | 125k | 37.93 | |
| Kyverna Therapeutics (KYTX) | 0.6 | $3.7M | 150k | 24.84 | |
| Arvinas Ord (ARVN) | 0.5 | $2.9M | 71k | 41.28 |
